Stock Rating Upgrade
The Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Astrazeneca PLC (NASDAQ: AZN) stock declined by -2.8% on 11/15/24. The shares closed at $63.23. Moreover, trading volume in this decline was above average at 140% of normal. Relative to the market the stock has been strong over the last nine months but has declined -2.3% during the last week.
Current PriceTarget Research Rating
Astrazeneca has a current Value Trend Rating of B (Positive). This VT Rating rose significantly in recent days from C previously. This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Astrazeneca has a neutral Power Rating of 53 but a very high Appreciation Score of 91, resulting in the Positive Value Trend Rating.
Be the first to comment